Gilead Sciences (GILD) Short Interest Ratio & Short Volume

Short interest is the volume of Gilead Sciences shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 21,180,000 shares of GILD short. Learn More on Gilead Sciences' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GILD shares currently have a short interest ratio of 3.0. Learn More on Gilead Sciences's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Gilead Sciences: Simplex Trading LLC, IMC Chicago LLC, Nomura Holdings Inc., Readystate Asset Management LP, Parallax Volatility Advisers L.P., Capital Fund Management S.A., Eisler Capital US LLC, Eisler Capital UK Ltd., Capstone Investment Advisors LLC, Allianz Asset Management GmbH, Hsbc Holdings PLC, Mendel Money Management, IMC Chicago LLC, Wells Fargo & Company MN, UBS Group AG, BNP Paribas Financial Markets, Concourse Financial Group Securities Inc., and Genus Capital Management Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Gilead Sciences saw a decrease in short interest in April. As of April 15th, there was short interest totaling 21,180,000 shares, a decrease of 6.2% from the previous total of 22,570,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to Gilead Sciences: Seagen Inc. (5.10%), Biogen Inc. (2.26%), Amgen Inc. (1.89%), Moderna, Inc. (6.24%), argenx SE (2.24%), BioNTech SE (1.33%), HCA Healthcare, Inc. (1.38%), GSK plc (0.36%), McKesson Co. (1.05%), Zoetis Inc. (0.70%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks.

Short selling GILD is an investing strategy that aims to generate trading profit from Gilead Sciences as its price is falling. GILD shares are trading up $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Gilead Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GILD, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GILD, twice per month. The most recent reporting period available is April, 15 2024.